Enabling technologies
to realize their full
potential
Our experienced operators have successfully commercialized numerous innovations – from early stage to over $1B in scale.
Large corporations invest billions in R&D, yet the majority of the value remains stranded within different programs or divisions. This is not due to any weakness in the technology, but often to shifts in funding or because technologies address markets outside the company’s focus. While consulting firms can help shortlist marketable innovations, they lack the ability to commercialize them. That’s where Catalyze Partners comes in. We leverage turnkey capabilities to spin out market-ready technologies into startup companies, enabling innovators to recoup R&D investment at no risk to their business.
For Innovators, Catalyze Is All Upside
Catalyze leaders are operators first and foremost. We understand the intrinsic nature of startups, what it takes to grow them into $100 million+ businesses, and have successfully done so in numerous commercialization efforts, from early stages to over $1 billion in scale. Our repeatable model enables innovators to capitalize on their technology investments — whether acquired or through R&D — providing an avenue for otherwise stranded technologies to realize their full market potential.
Low-Risk, Low-Resource Investment
Our repeatable process for monetizing technology means Catalyze takes on all the work — securing funding, delivering market strategies, overseeing staffing and all the other critical elements that come with launching and growing a startup.
More Markets and Future Ideas
Speed to Market and Monetary Gain
Continued Revenue Opportunities
R&D teams are challenged to push the boundaries of innovation, yet not all discoveries end up being aligned with changing corporate business objectives. These innovations fall into a valley of death where the corporation is ill-suited to successfully commercialize the technology to meet its full potential. Catalyze fills this gap and provides the corporations a way to monetize their substantial investments in R&D with little risk or effort.